Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.

The oncologist（2022）

引用 4|浏览24

暂无评分

摘要

This real-world study provides evidence of the activity of cabozantinib in TRCC, with more durable responses than those observed historically with other VEGFR-TKIs or ICIs.

查看译文

关键词

MiT family translocation renal cell carcinoma,cabozantinib,non-clear cell renal cell carcinoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要